|
|
|
201-500 employees
View all
|
|
Research
|
|
15 Chemin Camille-Vidart, Geneva, CH
|
|
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives.
We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials.
When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.
|
Drugs For Neglected Diseases Initiative - DNDi Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
80%
|
The widely used Drugs For Neglected Diseases Initiative - DNDi email format is {f}{last} (e.g. [email protected]) with 80% adoption across the company.
To contact Drugs For Neglected Diseases Initiative - DNDi customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.